Boosted Memory and Improved Brain Bioavailability of Rivastigmine: Targeting Effort to the Brain Using Covalently Tethered Lower Generation PAMAM Dendrimers with Lactoferrin

Molecular Pharmaceutics
Avinash GothwalUmesh Gupta

Abstract

Currently, there is no treatment strategy which can reverse the process of neuro-degeneration in progression of Alzheimer's disease (AD). Practically, it is desired to achieve and maintain high therapeutic doses in the brain, but it is hard due to selective permeability of the blood-brain barrier (BBB). In the present study, lactoferrin (Lf) was conjugated to polyamidoamine generation 3.0 (PAMAM G3.0) dendrimers for the effective delivery of rivastigmine (RIV) to the brain. Conjugation of PAMAM G3.0 with lactoferrin was confirmed by FT-IR, 1H NMR, and 2D-NMR spectroscopy as well as AFM techniques. Further, RIV was loaded into PAMAM G3.0 and PAMAM-Lf conjugates. RP-HPLC was used to quantify the drug loading and release as well. Spectroscopic analysis confirmed PAMAM-Lf conjugation, the size of the conjugate was 100.04 ± 3.1 nm, and after RIV loading, the size was increased up to 216.13 ± 2.3 nm. Atomic force microscopic results revealed that the root-mean-square roughness ( Rq) and surface roughness ( Ra) were 6.31 and 5.27 nm, respectively, along with other parameters, Skewness and Kurtosis, which were 0.522 and 2.50, respectively. In vitro drug release from the PAMAM-Lf-RIV conjugate was sustained up to more than 100 h, and th...Continue Reading

References

Nov 8, 1984·Nature·W A JefferiesD Y Mason
May 12, 1998·Acta Neurologica Scandinavica·N R CutlerP Zolnouni
Apr 28, 2009·International Journal of Clinical Practice·A KurzG Lefèvre
Dec 1, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Swati KoppuChristine Dufès
Dec 15, 2010·Trends in Cognitive Sciences·Masud Husain, Mitul A Mehta
Jul 1, 2011·International Journal of Applied & Basic Medical Research·Uma A BhosaleRahul S Somani
Oct 24, 2014·Annual Review of Pharmacology and Toxicology·Jason M Lajoie, Eric V Shusta
Sep 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sukrut SomaniChristine Dufès
Mar 25, 2017·International Journal of Molecular Sciences·Bhairavi SrinageshwarJulien Rossignol

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.